EULAR 2019 - Press conference: Rapid remission of proteinuria in lupus nephritis

The results of this study presented at the Annual European Congress of Rheumatology (EULAR 2019) suggest maintenance therapy with cyclosporine (CYA) results in more rapid remission of proteinuria compared to mycophenolate mofetil (MMF) or azathioprine (AZA) in patients with lupus nephritis. The efficacy of CYA, MMF and AZA in obtaining and maintaining remission of lupus nephritis (LN) is comparable over the long term.

Press conference title (full): Cyclosporine benefits patients through more rapid remission of proteinuria in lupus nephritis.

Spokesperson: Lorenza Maria Argolini. Rheumatology Consultant of the Lupus Clinic, ASST Pini CTO, Milan, Italy.

Abstract number: OP0046

Always consult your rheumatologist or healthcare provider for personalised medical advice or any questions regarding a medical condition and/or treatment.